Once the study has been deemed feasible, it is worth contacting any support service teams which need to negotiate agreements with third party organisations.
This is particularly the case with pharmacy, where technical agreements with pharmaceutical companies (to cover processes applied to the IMP such as packaging, manufacture and radiolabelling) can be time-consuming. Early notification that the study is going to proceed will be appreciated.
Resources
| Type | Where to find |
|---|---|
| Key contacts | JRO; Pharmacy |
| Useful links | NIHR Clinical Trials Toolkit - trial supplies |
| NIHR benchmark | Prior to NIHR 70-day benchmark |
| Process map links | This activity occurs in the feasibility stage: > Imperial College London as sponsor > Imperial College Hospital NHS Trust as sponsor |